Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Erika Ruiz Garcia"'
Autor:
E. Gabriela Chiorean, Govind Nandakumar, Temidayo Fadelu, Sarah Temin, Ashley Efrain Alarcon-Rozas, Suyapa Bejarano, Adina-Emilia Croitoru, Surbhi Grover, Pritesh V. Lohar, Andrew Odhiambo, Se Hoon Park, Erika Ruiz Garcia, Catherine Teh, Azmina Rose, Bassem Zaki, Mary D. Chamberlin
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 414-438 (2020)
PURPOSETo provide expert guidance to clinicians and policymakers in resource-constrained settings on the management of patients with late-stage colorectal cancer.METHODSASCO convened a multidisciplinary, multinational Expert Panel that reviewed exist
Externí odkaz:
https://doaj.org/article/5cb5a49caa144bd8be0e87acef504fc8
Autor:
Daniel De‐la‐Rosa‐Martinez, Mercedes Aranda‐Audelo, Alexandra Martin‐Onraet, Beda Islas‐Muñoz, Carolina Perez‐Jimenez, Pamela Alatorre‐Fernandez, Patricia Cornejo‐Juarez, Erika Ruiz‐Garcia, Paola Zinser‐Peniche, Luis Nuñez‐Luna, Abelardo Meneses‐Garcia, Angel Herrera‐Gomez, Diana Vilar‐Compte
Publikováno v:
Cancer Medicine, Vol 11, Iss 8, Pp 1827-1836 (2022)
Abstract Background Literature on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection in cancer patients is scarce in Latin America. This population seems to have a higher risk for adverse outcomes. This study aims to correlate
Externí odkaz:
https://doaj.org/article/4d334c0ffe6e430ca6e6c65aecf615a5
Autor:
Erika Ruiz-Garcia, Adriana Peña-Nieves, Jorge Alegria-Baños, Patricia Cornejo-Juarez, Abelardo Meneses-García, Samuel Rivera Rivera, Juan José Sánchez, Raquel Gerson-Cwilich, Daniela Shveid Gerson, Heriberto Medina Franco, Gabriela Alejandra Buerba, Alicia Acosta Espinoza, Norma Valencia Mijares, Edith A. Fernández-Figueroa, Roberto A. Vázquez, Diana Vilar-Compte
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 12 (2021)
Purpose: The aim of this study was to evaluate the demographic characteristics, clinical and pathological factors, and the outcome of cancer and COVID-19 patients in Mexico. Patients and methods: A prospective, multicentric study was performed throug
Externí odkaz:
https://doaj.org/article/a3fe4e28761f4e47b96c52bd9c509f1b
Autor:
Michael J. Wagner, Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann, Diana Vilar-Compte, Erika Ruiz-Garcia, Matthew Ingham, Gary K. Schwartz, Corrie A. Painter, Rashmi Chugh, Leslie Fecher, Cathleen Park, Olga Zamulko, Jonathan C. Trent, Vivek Subbiah, Ali Raza Khaki, Lisa Tachiki, Elizabeth S. Nakasone, Elizabeth T. Loggers, Chris Labaki, Renee Maria Saliby, Rana R. McKay, Archana Ajmera, Elizabeth A. Griffiths, Igor Puzanov, William D. Tap, Clara Hwang, Sheela Tejwani, Sachin R. Jhawar, Brandon Hayes-Lattin, Elizabeth Wulff-Burchfield, Anup Kasi, Daniel Y. Reuben, Gayathri Nagaraj, Monika Joshi, Hyma Polimera, Amit A. Kulkarni, Khashayar Esfahani, Daniel H. Kwon, Luca Paoluzzi, Mehmet A. Bilen, Eric B. Durbin, Petros Grivas, Jeremy L. Warner, Elizabeth J. Davis
Publikováno v:
Cancers, Vol 14, Iss 17, p 4334 (2022)
Background: Patients with sarcoma often require individualized treatment strategies and are likely to receive aggressive immunosuppressive therapies, which may place them at higher risk for severe COVID-19. We aimed to describe demographics, risk fac
Externí odkaz:
https://doaj.org/article/735e020710c64a6fa57415fde1bc8ccd
Autor:
Ziad, Bakouny, Chris, Labaki, Punita, Grover, Joy, Awosika, Shuchi, Gulati, Chih-Yuan, Hsu, Saif I, Alimohamed, Babar, Bashir, Stephanie, Berg, Mehmet A, Bilen, Daniel, Bowles, Cecilia, Castellano, Aakash, Desai, Arielle, Elkrief, Omar E, Eton, Leslie A, Fecher, Daniel, Flora, Matthew D, Galsky, Margaret E, Gatti-Mays, Alicia, Gesenhues, Michael J, Glover, Dharmesh, Gopalakrishnan, Shilpa, Gupta, Thorvardur R, Halfdanarson, Brandon, Hayes-Lattin, Mohamed, Hendawi, Emily, Hsu, Clara, Hwang, Roman, Jandarov, Chinmay, Jani, Douglas B, Johnson, Monika, Joshi, Hina, Khan, Shaheer A, Khan, Natalie, Knox, Vadim S, Koshkin, Amit A, Kulkarni, Daniel H, Kwon, Sara, Matar, Rana R, McKay, Sanjay, Mishra, Feras A, Moria, Amanda, Nizam, Nora L, Nock, Taylor K, Nonato, Justin, Panasci, Lauren, Pomerantz, Andrew J, Portuguese, Destie, Provenzano, Matthew, Puc, Yuan J, Rao, Terence D, Rhodes, Gregory J, Riely, Jacob J, Ripp, Andrea V, Rivera, Erika, Ruiz-Garcia, Andrew L, Schmidt, Adam J, Schoenfeld, Gary K, Schwartz, Sumit A, Shah, Justin, Shaya, Suki, Subbiah, Lisa M, Tachiki, Matthew D, Tucker, Melissa, Valdez-Reyes, Lisa B, Weissmann, Michael T, Wotman, Elizabeth M, Wulff-Burchfield, Zhuoer, Xie, Yuanchu James, Yang, Michael A, Thompson, Dimpy P, Shah, Jeremy L, Warner, Yu, Shyr, Toni K, Choueiri, Trisha M, Wise-Draper, Catherine, Stratton
Publikováno v:
JAMA oncology.
ImportanceCytokine storm due to COVID-19 can cause high morbidity and mortality and may be more common in patients with cancer treated with immunotherapy (IO) due to immune system activation.ObjectiveTo determine the association of baseline immunosup
Autor:
German Calderillo Ruiz, Horacio Lopez Basave, Rafael Sebastian Vazquez Renteria, Alison Castillo Morales, Alberto Guijosa, Carolina Castillo Morales, Marytere Herrera, Consuelo Diaz, Ezequiel Vazquez Cortes, Erika Ruiz-Garcia, Wendy R. Munoz Montano
Publikováno v:
Journal of Oncology. 2022:1-11
Background. Survival and recurrence rates following locoregional colon cancer surgical resection are highly variable. Currently used tools to assess patient risk are still imperfect. In the present work, we evaluate, for the first time, the prognosti
Autor:
Nancy N. Baxter, Erin B. Kennedy, Emily Bergsland, Jordan Berlin, Thomas J. George, Sharlene Gill, Philip J. Gold, Alex Hantel, Lee Jones, Christopher Lieu, Najjia Mahmoud, Arden M. Morris, Erika Ruiz-Garcia, Y. Nancy You, Jeffrey A. Meyerhardt
Publikováno v:
Journal of Clinical Oncology. 40:892-910
PURPOSE To develop recommendations for adjuvant therapy for patients with resected stage II colon cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of relevant studies and develop recommendations for clinical practice. RESU
Autor:
Consuelo Diaz-Romero, Virgilio Souza e Silva, Iara K.F. Lustosa, Erika Ruiz-Garcia, Celso Abdon Lopes de Mello, Romina Luca, Juan Manuel O'Connor, Sinara Figueiredo Silva, Guillermo Mendez, Marcos Pedro Guedes Camandaroba, Bruna Raphaeli Silva Mattos, Rachel P. Riechelmann
Publikováno v:
Clinical Colorectal Cancer. 20:299-304
Background HIV-positive patients are underrepresented in clinical trials of metastatic squamous cell carcinoma of the anal canal (mSCCA). We aimed to compare the clinical outcomes of mSCCA patients according to HIV infection. Methods This was a retro
Autor:
Rodrigo Villaseñor-Echavarri, Daniel De-la-Rosa-Martinez, Emmanuel Frias-Jimenez, Alexandra Martin-Onraet, Erika Ruiz-Garcia, Alonso Cruz-Cruz, Luis Alonso Herrera-Montalvo, Diana Vilar-Compte
Publikováno v:
Open Forum Infectious Diseases. 9
Background Cancer patients (CPs) with COVID-19 have an increased risk of adverse outcomes. In addition, CPs seem to have a lower immune response to SARS-CoV-2 vaccination. This study aimed to evaluate SARS-CoV-2 spike antibodies (anti-S Abs) followin
Autor:
Jennifer Y. Wo, Christopher J. Anker, Jonathan B. Ashman, Nishin A. Bhadkamkar, Lisa Bradfield, Daniel T. Chang, Jennifer Dorth, Julio Garcia-Aguilar, David Goff, Dustin Jacqmin, Patrick Kelly, Neil B. Newman, Jeffrey Olsen, Ann C. Raldow, Erika Ruiz-Garcia, Karyn B. Stitzenberg, Charles R. Thomas, Q. Jackie Wu, Prajnan Das
Publikováno v:
Practical Radiation Oncology. 11:13-25